New drug shows promise for kidney disease in early trial

NCT ID NCT05174221

Completed Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a drug called mezagitamab in 17 people with IgA nephropathy, a kidney disease. The main goal was to check for side effects and see how the body processes the drug. Participants received injections under the skin for several weeks and were monitored for up to 96 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glomerulonephritis IgA glomerulonephritis impaired renal function disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLOMERULONEPHRITIS KIDNEY DISEASE

Contacts and locations

Show contact details

Locations

ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia

Brescia, Lombardy, 25123, Italy
Ajou University Hospital

Suwon, 16499, South Korea
Amicis Research Center - Northridge - Nordhoff

Northridge, California, 91324, United States
Beijing Friendship Hospital,Capital Medical University

Beijing, Beijing Municipality, 100050, China
Boise Kidney and Hypertension Institute - Frenova

Nampa, Idaho, 83687, United States
Core Research Group

Milton, Queensland, 4064, Australia
Fujita Health University Hospital

Toyoake-shi, Aiti, 470-1192, Japan
Fundacio Puigvert

Barcelona, 8025, Spain
Guangdong Provincial Peoples Hospital

Guangzhou, Guangdong, 510080, China
Hiroshima University Hospital

Hiroshima, Hiroshima, 734-8551, Japan
Hospital Universitario Marques de Valdecilla

Santander, Cantabria, 39008, Spain
Hospital Universitario Vall d'Hebron - PPDS

Barcelona, 08035, Spain
Hull Royal Infirmary

Hull, HU3 2JZ, United Kingdom
Kasugai Municipal Hospital

Kasugai-Shi, Aiti, 486-0804, Japan
Leicester General Hospital

Leicester, Leicestershire, LE5 4PW, United Kingdom
Monash Health, Monash Medical Centre

Clayton, Victoria, 3168, Australia
National Taiwan University Hospital

Taipei, 100, Taiwan
National University Hospital- Singapore

Singapore, 119074, Singapore
NorthShore University HealthSystem

Evanston, Illinois, 60201, United States
Royal Melbourne Hospital

Parkville, Victoria, 3050, Australia
Sapporo City General Hospital

Sapporo, Hokkaido, 060-8604, Japan
Semmelweis Egyetem

Budapest, 1083, Hungary
Seoul National University Hospital

Seoul, Seoul Teugbyeolsi, 03080, South Korea
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont

Szeged, Csongrád megye, 6720, Hungary
Taipei Medical University Shuang Ho Hospital

New Taipei City, 23561, Taiwan
The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710061, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.